Multiple sclerosis and hypogonadism: is there a relationship?

The majority of reviewed articles described a positive correlation between low testosterone levels and HPG axis dysfunction in individuals with MS.

• 11 of 19 articles described a positive correlation between low testosterone levels and dysfunction within the hypothalamic-pituitary-gonadal (HPG) axis in individuals with MS.
• Articles were published between November 2008 and March 2022.
• The search was conducted using PubMed database with terms including 'multiple sclerosis,' 'testosterone,' 'hypogonadism,' and 'MS and testosterone levels.'
• Low testosterone levels were suggested to contribute to dysfunction within the hypothalamus-pituitary-gonadal axis, which plays a crucial role in regulating testosterone production.

A relationship was found between sexual dysfunction and low testosterone levels in patients with MS.

• The reviewed articles showed a relationship between sexual dysfunction and low testosterone levels.
• A positive correlative relationship between sexual dysfunction and low testosterone levels was identified across the reviewed literature.
• MS is widely recognized as a disease primarily affecting women, adding complexity to the testosterone-MS relationship.
• The relationship between MS and hypogonadism was described as complex and not fully understood.

Hypogonadism may have a significant impact on quality of life and disease progression in patients with MS.

• Recent evidence reviewed indicated that hypogonadism may have a significant impact on the quality of life of patients with MS.
• Hypogonadism was also identified as potentially impacting disease progression in MS patients.
• The review examined potential benefits and drawbacks of testosterone replacement therapy for patients with both MS and hypogonadism.
• 19 articles were analyzed in total for this scientific review.

The evidence on testosterone replacement therapy for MS patients with hypogonadism remains inconclusive, requiring further research.

• The review examined potential benefits and drawbacks of testosterone replacement therapy for patients with MS and hypogonadism.
• The authors concluded that further research is needed to better understand the effects of testosterone therapy on MS and sexual dysfunction in patients with MS.
• The relationship among MS, testosterone levels, and the HPG axis was described as complex.
• The mechanisms underlying the relationship between MS and hypogonadism were not fully understood based on current literature.